Literature DB >> 20694791

Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.

Marcelo F Montenegro1, Evandro M Neto-Neves, Carlos A Dias-Junior, Carla S Ceron, Michele M Castro, Valeria A Gomes, Alexandre Kanashiro, Jose E Tanus-Santos.   

Abstract

Quercetin has antioxidants properties which may increase nitric oxide (NO) bioavailability. However, the effects of quercetin on NO status have been poorly studied. We evaluated whether quercetin improves the plasma levels of NO metabolites in two-kidney one-clip (2K1C) hypertensive rats and assessed its effect on endothelial function. Sham-operated and 2K1C rats were treated with quercetin (10 mg(-1) kg(-1) day(-1) by gavage) or vehicle for 3 weeks. Systolic blood pressure (SBP) was monitored weekly. Vascular responses to acetylcholine (Ach) and sodium nitroprusside (SNP) were assessed in hindquarter vascular bed. Plasma nitrate levels were assessed by Griess reagent and plasma nitrite and nitroso species (S, N-nitroso species) were assessed by ozone- based chemiluminescence. Aortic NADPH oxidase activity and superoxide production were evaluated. While quercetin had no effects in control normotensive rats (P > 0.05), it significantly reduced SBP in 2K1C rats (P < 0.05). At the end of treatment, plasma nitrate levels were similar in all experimental groups (P > 0.05). However, plasma nitrite and the nitroso species levels were significantly lower in 2K1C rats when compared with controls (P < 0.05). Quercetin treatment restored plasma nitrite and nitroso species levels to those found in the sham-vehicle group (P < 0.05). While quercetin treatment induced no significant changes in responses to SNP (P > 0.05), it restored the vascular responses to Ach. Quercetin significantly attenuated 2K1C-hypertension-induced increases in NADPH oxidase activity and vascular superoxide production (P < 0.05). These results suggest that the antihypertensive effects of quercetin were associated with increased NO formation and improved endothelial function, which probably result from its antioxidant effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694791     DOI: 10.1007/s00210-010-0546-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Authors:  T Lauer; M Preik; T Rassaf; B E Strauer; A Deussen; M Feelisch; M Kelm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet.

Authors:  Yukiko Yamamoto; Eriko Oue
Journal:  Biosci Biotechnol Biochem       Date:  2006-04       Impact factor: 2.043

3.  Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.

Authors:  I F Metzger; J T C Sertorio; J E Tanus-Santos
Journal:  Acta Physiol (Oxf)       Date:  2006-10       Impact factor: 6.311

4.  Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans.

Authors:  Petra Kleinbongard; André Dejam; Thomas Lauer; Thomas Jax; Stefan Kerber; Putrika Gharini; Jan Balzer; Rainer B Zotz; Rüdiger E Scharf; Reinhart Willers; Alan N Schechter; Martin Feelisch; Malte Kelm
Journal:  Free Radic Biol Med       Date:  2005-11-10       Impact factor: 7.376

5.  Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta.

Authors:  Manuel Sanchez; Federica Lodi; Rocio Vera; Inmaculada C Villar; Angel Cogolludo; Rosario Jimenez; Laura Moreno; Miguel Romero; Juan Tamargo; Francisco Perez-Vizcaino; Juan Duarte
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

6.  Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia.

Authors:  Valeria C Sandrim; Marcelo F Montenegro; Ana C T Palei; Ingrid F Metzger; Jonas T C Sertorio; Ricardo C Cavalli; Jose E Tanus-Santos
Journal:  Free Radic Biol Med       Date:  2010-05-25       Impact factor: 7.376

7.  The antihypertensive effects of quercetin in a salt-sensitive model of hypertension.

Authors:  I Mackraj; T Govender; S Ramesar
Journal:  J Cardiovasc Pharmacol       Date:  2008-03       Impact factor: 3.105

8.  Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.

Authors:  Milagros Galisteo; Maria Francisca García-Saura; Rosario Jiménez; Inmaculada Concepción Villar; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

9.  Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.

Authors:  Marcio L L Martinez; Michele M Castro; Elen Rizzi; Karla Fernandes; Caroline Demacq; Lusiane M Bendhack; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Eur J Pharmacol       Date:  2008-07-02       Impact factor: 4.432

Review 10.  Antihypertensive effects of the flavonoid quercetin.

Authors:  Francisco Perez-Vizcaino; Juan Duarte; Rosario Jimenez; Celestino Santos-Buelga; Antonio Osuna
Journal:  Pharmacol Rep       Date:  2009 Jan-Feb       Impact factor: 3.024

View more
  16 in total

1.  Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats.

Authors:  Putcharawipa Maneesai; Sarawoot Bunbupha; Upa Kukongviriyapan; Laddawan Senggunprai; Veerapol Kukongviriyapan; Parichat Prachaney; Poungrat Pakdeechote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-21       Impact factor: 3.000

2.  eNOS polymorphism associated with metabolic syndrome in children and adolescents.

Authors:  Josiane A Miranda; Vanessa A Belo; Débora C Souza-Costa; Carla M M Lanna; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2012-09-15       Impact factor: 3.396

3.  Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension.

Authors:  Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Diogo M O Marçal; Ana C T Palei; Antonio J Costa-Filho; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-20       Impact factor: 3.000

4.  Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.

Authors:  Diogo M O Marçal; Elen Rizzi; Alisson Martins-Oliveira; Carla S Ceron; Danielle A Guimaraes; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

5.  Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism.

Authors:  Ozelia Sousa-Santos; Evandro M Neto-Neves; Karina C Ferraz; Carla S Ceron; Elen Rizzi; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

6.  Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension.

Authors:  Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Graziele C Ferreira; Rafael L Portella; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06       Impact factor: 3.000

7.  Quercetin supplementation: insight into the potentially harmful outcomes of neurodegenerative prevention.

Authors:  Maja Jazvinšćak Jembrek; Ana Čipak Gašparović; Lidija Vuković; Josipa Vlainić; Neven Žarković; Nada Oršolić
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-17       Impact factor: 3.000

8.  Emerging country pharmacology: a 10-year perspective from Naunyn-Schmiedeberg's Archives of Pharmacology.

Authors:  Marcio M Coelho; Irmgard Tegeder; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-09       Impact factor: 3.000

9.  Sevoflurane Induces DNA Damage Whereas Isoflurane Leads to Higher Antioxidative Status in Anesthetized Rats.

Authors:  Thalita L A Rocha; Carlos A Dias-Junior; Jose S Possomato-Vieira; Victor H Gonçalves-Rizzi; Flávia R Nogueira; Kátina M de Souza; Leandro G Braz; Mariana G Braz
Journal:  Biomed Res Int       Date:  2015-05-25       Impact factor: 3.411

10.  Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.

Authors:  Danielle A Guimarães; Elen Rizzi; Carla S Ceron; Lucas C Pinheiro; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Redox Biol       Date:  2013-11-17       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.